Connolly Sarah T. Bristol Myers Squibb CO Transaction History

Connolly Sarah T.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $276,692 - $307,223	-4,343 Reduced 13.18%	28,614 $1.83 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $701,454 - $795,607	10,675 Added 47.91%	32,957 $2.28 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $8,491 - $10,055	124 Added 0.56%	22,282 $1.6 Million
Q3 2022 Nov 09, 2022	BUY	$0.13 - $76.84 $792 - $468,647	6,099 Added 37.98%	22,158 $1.58 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $475,370 - $523,549	6,546 Added 68.81%	16,059 $1.24 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $208,294 - $249,763	3,388 Added 55.31%	9,513 $695,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $353,657 - $400,758	6,125 New	6,125 $380,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Connolly Sarah T., based on Form 13F filings with the SEC.

Stay updated on Connolly Sarah T. with notifications on news.